title: T315I, more or less, predicts for major molecular response: the devil is in the details!
authors: Michael J
authors: MJ
authors: Mauro
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069439:Dasatinib; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D009154:Mutation; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D016044:Fusion Proteins, bcr-abl; C498826:nilotinib; D000069439:Dasatinib
references: Haematologica. 2008 Feb;93(2):186-92
references: 18223278
references: N Engl J Med. 2012 Nov 29;367(22):2075-88
references: 23190221
references: Blood. 2009 Dec 24;114(27):5426-35
references: 19880502
references: Haematologica. 2013 May;98(5):714-7
references: 23065514
references: Blood. 2011 Jan 20;117(3):755-63
references: 20966165
references: N Engl J Med. 2001 Apr 5;344(14):1031-7
references: 11287972
references: Blood. 2013 Jan 17;121(3):489-98
references: 23223358
references: Science. 2001 Aug 3;293(5531):876-80
references: 11423618
references: Blood. 2012 Sep 27;120(13):2573-80
references: 22896000
references: Blood. 2009 Dec 17;114(26):5271-8
references: 19843886
references: Blood. 2002 Aug 1;100(3):1014-8
references: 12130516
references: Blood. 2011 Aug 4;118(5):1208-15
references: 21562040